Benjamin F. Edwards & Company, Inc. Compugen LTD Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.68 - $1.11 $1,360 - $2,220	-2,000 Reduced 90.91%	200 $0
Q4 2022 Feb 07, 2023	SELL	$0.58 - $1.2 $417 - $864	-720 Reduced 24.66%	2,200 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $471 - $999	-300 Reduced 9.32%	2,920 $5,000
Q1 2022 May 04, 2022	SELL	$2.76 - $4.64 $6,844 - $11,507	-2,480 Reduced 43.51%	3,220 $11,000
Q4 2021 Feb 07, 2022	SELL	$4.09 - $7.16 $16,769 - $29,356	-4,100 Reduced 41.84%	5,700 $25,000
Q3 2021 Nov 02, 2021	SELL	$5.8 - $8.02 $5,220 - $7,218	-900 Reduced 8.41%	9,800 $59,000
Q2 2021 Aug 11, 2021	SELL	$6.87 - $9.16 $75,570 - $100,760	-11,000 Reduced 50.69%	10,700 $89,000
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $166,439 - $298,809	-21,700 Reduced 50.0%	21,700 $186,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $540,912 - $742,990	38,200 Added 734.62%	43,400 $705,000
Q2 2020 Aug 14, 2020	SELL	$6.97 - $17.12 $39,729 - $97,584	-5,700 Reduced 52.29%	5,200 $78,000
Q1 2020 May 07, 2020	SELL	$5.79 - $11.83 $2,026 - $4,140	-350 Reduced 3.11%	10,900 $79,000
Q4 2019 Feb 06, 2020	SELL	$3.9 - $6.16 $91,455 - $144,452	-23,450 Reduced 67.58%	11,250 $67,000
Q3 2019 Nov 05, 2019	SELL	$3.01 - $4.49 $85,785 - $127,965	-28,500 Reduced 45.09%	34,700 $147,000
Q2 2019 Aug 08, 2019	SELL	$2.8 - $4.14 $176,680 - $261,233	-63,100 Reduced 49.96%	63,200 $243,000
Q1 2019 May 15, 2019	SELL	$2.35 - $4.19 $26,790 - $47,766	-11,400 Reduced 8.28%	126,300 $523,000
Q4 2018 Jan 31, 2019	SELL	$2.17 - $3.8 $60,543 - $106,020	-27,900 Reduced 16.85%	137,700 $299,000
Q3 2018 Oct 29, 2018	SELL	$3.0 - $4.05 $6,000 - $8,100	-2,000 Reduced 1.19%	165,600 $638,000
Q2 2018 Jul 19, 2018	BUY	$3.15 - $4.7 $135,135 - $201,630	42,900 Added 34.4%	167,600 $553,000
Q1 2018 Apr 17, 2018	BUY	$2.5 - $4.45 $98,500 - $175,330	39,400 Added 46.19%	124,700 $534,000
Q4 2017 Jan 17, 2018	BUY	$2.35 - $4.0 $52,416 - $89,220	22,305 Added 35.41%	85,300 $213,000
Q3 2017 Oct 24, 2017	BUY	$2.75 - $3.95 $173,236 - $248,830	62,995	62,995 $239,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

Silverarc Capital Management, LLC

1.5M
Shares

$2.27 Million
0.68% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.29M
Shares

$1.94 Million
0.0% of portfolio
Taylor Frigon Capital Management LLC

1.2M
Shares

$1.81 Million
1.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

1.09M
Shares

$1.65 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

1.02M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account